I. Takizawa

发表

Estrogen receptor alpha controls gene expression via translational offsetting

Krzysztof J. Szkop, Sebastian A. Leidel, S. Leidel, 2018, bioRxiv.

Primary gastrointestinal stromal tumor in the retroperitoneum

N. Hara, I. Takizawa, I. Emura, 2006, International journal of urology : official journal of the Japanese Urological Association.

Adrenocorticotropic hormone is involved in regulation of androgen synthesis in men receiving androgen deprivation therapy for localized prostate cancer.

N. Hara, Kota Takahashi, T. Nishiyama, 2010, The Journal of urology.

Deficiency in androgens and upregulation of insulin-like growth factor-1 are involved in high bone turnover in men receiving androgen deprivation therapy for prostate cancer.

T. Kawasaki, N. Hara, Kota Takahashi, 2012, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

External validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese patients receiving radical prostatectomy.

K. Akazawa, T. Kawasaki, N. Hara, 2011, Japanese journal of clinical oncology.

Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study

N. Hara, H. Koike, M. Kawaguchi, 2012, Diagnostic Pathology.

Serum prostate‐specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu

N. Hara, Kota Takahashi, T. Nishiyama, 2010, The Prostate.

Intraoperative intraocular pressure changes during robot-assisted radical prostatectomy: associations with perioperative and clinicopathological factors

Y. Tomita, N. Hara, T. Fukuchi, 2020, BMC Urology.

Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer

T. Kawasaki, N. Hara, M. Naito, 2013, Scientific Reports.

A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer.

K. Tabata, H. Uemura, N. Matsubara, 2015, Japanese journal of clinical oncology.

Altered association of interleukin‐6 with sex steroids in lipid metabolism disorder in men with prostate cancer receiving androgen deprivation therapy

T. Kawasaki, N. Hara, Kota Takahashi, 2012, The Prostate.

Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone

Y. Tomita, N. Hara, T. Nishiyama, 2016, Scientific Reports.

Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.

N. Hara, Kota Takahashi, T. Nishiyama, 2012, Urologic oncology.

Adult Prostate Stem Cells

G. Risbridger, M. Lawrence, C. Gargett, 2014 .

Bone metabolic disorder in patients with prostate cancer receiving androgen deprivation therapy (ADT): impact of ADT on the growth hormone/insulin‐like growth factor‐1/parathyroid hormone axis

N. Hara, Kota Takahashi, T. Nishiyama, 2009, The Prostate.

Enzalutamide‐induced severe thrombocytopenia complicated by a seizure in a 76‐year‐old man with castration‐resistant prostate cancer

Y. Tomita, N. Hara, I. Takizawa, 2018, IJU case reports.

Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis.

N. Hara, Toshihiro Saito, Y. Kitamura, 2010, Urology.

Low-Dose-Rate and High-Dose-Rate Brachytherapy for Localized Prostate Cancer in ABO-Incompatible Renal Transplant Recipients.

Y. Tomita, N. Hara, H. Aoyama, 2019, Transplantation proceedings.

Primary solitary fibrous tumor (SFT) in the retroperitoneum.

N. Hara, M. Kawaguchi, K. Arai, 2008, Urologic oncology.

Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity

R. Nadon, O. Larsson, I. Topisirovic, 2014, Oncotarget.

Translational offsetting as a mode of estrogen receptor α‐dependent regulation of gene expression

Krzysztof J. Szkop, Sebastian A. Leidel, S. Leidel, 2019, The EMBO journal.

A carbon 21 steroidal metabolite from progestin, 20β‐hydroxy‐5α‐dihydroprogesterone, stimulates the androgen receptor in prostate cancer cells

Y. Tomita, N. Hara, T. Nishiyama, 2018, The Prostate.

Limited significance of repeated long-term radiological and hormonal examination in nonfunctioning adrenal incidentalomas

Y. Tomita, M. Tasaki, T. Nishiyama, 2019, International braz j urol : official journal of the Brazilian Society of Urology.

Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification.

N. Hara, Kota Takahashi, T. Nishiyama, 2009, Asian journal of andrology.

Trilostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, has an agonistic activity on androgen receptor in human prostate cancer cells.

Fumio Ishizaki, N. Hara, Kota Takahashi, 2010, Cancer letters.